Cardinal Health, Inc. $CAH Stock Position Decreased by Hsbc Holdings PLC

Hsbc Holdings PLC trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 11.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 612,473 shares of the company’s stock after selling 81,872 shares during the period. Hsbc Holdings PLC’s holdings in Cardinal Health were worth $126,038,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Nordea Investment Management AB grew its position in Cardinal Health by 328.3% in the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after acquiring an additional 494,731 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after purchasing an additional 707,495 shares in the last quarter. Procyon Advisors LLC raised its holdings in shares of Cardinal Health by 78.7% during the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock valued at $3,499,000 after purchasing an additional 7,499 shares in the last quarter. Sierra Summit Advisors LLC acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at $9,897,000. Finally, Kornitzer Capital Management Inc. KS lifted its stake in shares of Cardinal Health by 100.8% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock valued at $3,733,000 after purchasing an additional 9,120 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.1%

NYSE CAH opened at $222.08 on Monday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The company has a fifty day simple moving average of $204.34 and a 200 day simple moving average of $209.28. The company has a market cap of $52.01 billion, a P/E ratio of 33.96, a P/E/G ratio of 1.21 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 31.19%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on CAH shares. TD Cowen upped their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Morgan Stanley boosted their price target on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. William Blair started coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Barclays increased their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Finally, Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.